Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Assets: 2013-2025

Historic Current Assets for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $639.5 million.

  • Amphastar Pharmaceuticals' Current Assets rose 17.13% to $639.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $639.5 million, marking a year-over-year increase of 17.13%. This contributed to the annual value of $534.1 million for FY2024, which is 9.08% up from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Current Assets stood at $639.5 million, which was up 10.10% from $580.8 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Current Assets high stood at $639.5 million for Q3 2025, and its period low was $300.2 million during Q1 2021.
  • Its 3-year average for Current Assets is $522.8 million, with a median of $543.0 million in 2023.
  • Data for Amphastar Pharmaceuticals' Current Assets shows a peak YoY skyrocketed of 41.33% (in 2023) over the last 5 years.
  • Amphastar Pharmaceuticals' Current Assets (Quarterly) stood at $318.1 million in 2021, then increased by 18.92% to $378.3 million in 2022, then grew by 29.41% to $489.6 million in 2023, then increased by 9.08% to $534.1 million in 2024, then grew by 17.13% to $639.5 million in 2025.
  • Its Current Assets stands at $639.5 million for Q3 2025, versus $580.8 million for Q2 2025 and $588.0 million for Q1 2025.